These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28408158)

  • 1. Validity of the activPAL3 activity monitor in people moderately affected by Multiple Sclerosis.
    Coulter EH; Miller L; McCorkell S; McGuire C; Algie K; Freeman J; Weller B; Mattison PG; McConnachie A; Wu O; Paul L
    Med Eng Phys; 2017 Jul; 45():78-82. PubMed ID: 28408158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and reliability of the activPAL3 for measuring posture and stepping in adults and young people.
    Sellers C; Dall P; Grant M; Stansfield B
    Gait Posture; 2016 Jan; 43():42-7. PubMed ID: 26669950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative validity of accelerometer-based measures of physical activity for people with multiple sclerosis.
    Coote S; O'Dwyer C
    Arch Phys Med Rehabil; 2012 Nov; 93(11):2022-8. PubMed ID: 22634293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The validity and reliability of a novel activity monitor as a measure of walking.
    Ryan CG; Grant PM; Tigbe WW; Granat MH
    Br J Sports Med; 2006 Sep; 40(9):779-84. PubMed ID: 16825270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which activity monitor to use? Validity, reproducibility and user friendliness of three activity monitors.
    Berendsen BA; Hendriks MR; Meijer K; Plasqui G; Schaper NC; Savelberg HH
    BMC Public Health; 2014 Jul; 14():749. PubMed ID: 25059233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does an accelerometer accurately measure steps taken under controlled conditions in adults with mild multiple sclerosis?
    Motl RW; Snook EM; Agiovlasitis S
    Disabil Health J; 2011 Jan; 4(1):52-7. PubMed ID: 21168808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of very slow stepping in healthy adults and validity of the activPAL3™ activity monitor in detecting these steps.
    Stansfield B; Hajarnis M; Sudarshan R
    Med Eng Phys; 2015 Jan; 37(1):42-7. PubMed ID: 25455167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecological validity of walking capacity tests in multiple sclerosis.
    Stellmann JP; Neuhaus A; Götze N; Briken S; Lederer C; Schimpl M; Heesen C; Daumer M
    PLoS One; 2015; 10(4):e0123822. PubMed ID: 25879750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis.
    Snook EM; Motl RW; Gliottoni RC
    Clin Rehabil; 2009 Mar; 23(3):248-58. PubMed ID: 19218299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criterion Validity of the activPAL Activity Monitor for Sedentary and Physical Activity Patterns in People Who Have Rheumatoid Arthritis.
    Larkin L; Nordgren B; Purtill H; Brand C; Fraser A; Kennedy N
    Phys Ther; 2016 Jul; 96(7):1093-101. PubMed ID: 26637646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a novel activity monitor in impaired, slow-walking, crutch-supported patients.
    van Laarhoven SN; Lipperts M; Bolink SA; Senden R; Heyligers IC; Grimm B
    Ann Phys Rehabil Med; 2016 Dec; 59(5-6):308-313. PubMed ID: 27659237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring actical accelerometers as an objective measure of physical activity in people with multiple sclerosis.
    Kayes NM; Schluter PJ; McPherson KM; Leete M; Mawston G; Taylor D
    Arch Phys Med Rehabil; 2009 Apr; 90(4):594-601. PubMed ID: 19345774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a wearable body monitoring device during treadmill walking and jogging in patients with fibromyalgia syndrome.
    Munguía-Izquierdo D; Santalla A; Legaz-Arrese A
    Arch Phys Med Rehabil; 2012 Jan; 93(1):115-22. PubMed ID: 22200390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rett syndrome: establishing a novel outcome measure for walking activity in an era of clinical trials for rare disorders.
    Downs J; Leonard H; Jacoby P; Brisco L; Baikie G; Hill K
    Disabil Rehabil; 2015; 37(21):1992-6. PubMed ID: 25495774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent Validity of activPAL and activPAL3 Accelerometers in Older Adults.
    Klenk J; Büchele G; Lindemann U; Kaufmann S; Peter R; Laszlo R; Kobel S; Rothenbacher D
    J Aging Phys Act; 2016 Jul; 24(3):444-50. PubMed ID: 26751290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exploratory study of two measures of free-living physical activity for people with multiple sclerosis.
    Klassen L; Schachter C; Scudds R
    Clin Rehabil; 2008 Mar; 22(3):260-71. PubMed ID: 18285434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and Concurrent Validity of the Narrow Path Walking Test in Persons With Multiple Sclerosis.
    Rosenblum U; Melzer I
    J Neurol Phys Ther; 2017 Jan; 41(1):43-51. PubMed ID: 27977520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calibration of accelerometer output for ambulatory adults with multiple sclerosis.
    Motl RW; Snook EM; Agiovlasitis S; Suh Y
    Arch Phys Med Rehabil; 2009 Oct; 90(10):1778-84. PubMed ID: 19801071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerometer cut-points derived during over-ground walking in persons with mild, moderate, and severe multiple sclerosis.
    Sandroff BM; Riskin BJ; Agiovlasitis S; Motl RW
    J Neurol Sci; 2014 May; 340(1-2):50-7. PubMed ID: 24635890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of the actibelt(®) accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis.
    Motl RW; Weikert M; Suh Y; Sosnoff JJ; Pula J; Soaz C; Schimpl M; Lederer C; Daumer M
    Gait Posture; 2012 Feb; 35(2):192-6. PubMed ID: 21945386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.